Sphingolipid profiles are altered in prefrontal cortex of rats under acute hyperglycemia

Neuroscience

Volumn 256, Issue , 2014, Pages 282-291

  Fiedorowicz, A ^a   Prokopiuk, S ^a   Zendzian Piotrowska, M ^a   Chabowski, A ^a   Car, H ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramides; Diabetes; Myriocin; Prefrontal cortex; Sphingomyelins

Indexed keywords

CERAMIDE; SATURATED FATTY ACID; SPHINGOLIPID; STREPTOZOCIN; UNSATURATED FATTY ACID; ANTINEOPLASTIC ANTIBIOTIC; IMMUNOSUPPRESSIVE AGENT; MONOUNSATURATED FATTY ACID; SPHINGOMYELIN; THERMOZYMOCIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; GAS LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CERAMIDES; DISEASE MODELS, ANIMAL; FATTY ACIDS, MONOUNSATURATED; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SPHINGOMYELINS; STATISTICS, NONPARAMETRIC; STREPTOZOCIN;

EID: 84888113971     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.10.022     Document Type: Article

References (47)

1. Aksu I., Ates M., Baykara B., Kiray M., Sisman A.R., Buyuk E., Baykara B., Cetinkaya C., Gumus H., Uysal N. Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett 2012, 531:176-181.
2. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 2003, 35:797-804.
3. Ben-David O., Futerman A.H. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. Neuromolecular Med 2010, 12:341-350.
4. Ben-David O., Pewzner-Jung Y., Brenner O., Laviad E.L., Kogot-Levin A., Weissberg I., Biton I.E., Pienik R., Wang E., Kelly S., Alroy J., Raas-Rothschild A., Friedman A., Brügger B., Merrill A.H., Futerman A.H. Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels. J Biol Chem 2011, 286:30022-30033.
5. Brismar T., Maurex L., Cooray G., Juntti-Berggren L., Lindström P., Ekberg K., Adner N., Andersson S. Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology 2007, 32:1041-1051.
6. Car H., Zendzian-Piotrowska M., Prokopiuk S., Fiedorowicz A., Sadowska A., Kurek K., Sawicka D. Ceramide profiles in the brain of rats with diabetes induced by streptozotocin. FEBS J 2012, 279:1943-1952.
7. Chun J., Hartung H.P. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 2010, 33:91-101.
8. Clodfelder-Miller B.J., Zmijewska A.A., Johnson G.V., Jope R.S. Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 2006, 55:3320-3325.
9. Coleman E., Judd R., Hoe L., Dennis J., Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004, 48:166-178.
10. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 2004, 101:2070-2075.
11. de Jager M., Gooris G., Ponec M., Bouwstra J. Acylceramide head group architecture affects lipid organization in synthetic ceramide mixtures. J Invest Dermatol 2004, 123:911-916.
12. de la Monte S.M., Wands J.R. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008, 2:1101-1113.
13. de Senna P.N., Ilha J., Baptista P.P., do Nascimento P.S., Leite M.C., Paim M.F., Gonçalves C.A., Achaval M., Xavier L.L. Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab Brain Dis 2011, 26:269-279.
14. Dobrzyn A., Gorski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise. Am J Physiol Endocrinol Metab 2002, 282:E277-E285.
15. Fiedorowicz A., Figiel I., Zaremba M., Dzwonek K., Schliebs R., Oderfeld-Nowak B. Trimethyltin-evoked apoptosis of murine hippocampal granule neurons is accompanied by the expression of interleukin-1beta and interleukin-1 receptor antagonist in cells of ameboid phenotype, the majority of which are NG2-positive. Brain Res Bull 2008, 77:19-26.
16. Folch J., Less M., Sloane S.G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
17. Fox T.E., Bewley M.C., Unrath K.A., Pedersen M.M., Anderson R.E., Jung D.Y., Jefferson L.S., Kim J.K., Bronson S.K., Flanagan J.M., Kester M. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res 2011, 52:509-517.
18. German O.L., Miranda G.E., Abrahan C.E., Rotstein N.P. Ceramide is a mediator of apoptosis in retina photoreceptors. Invest Ophthalmol Vis Sci 2006, 47:1658-1668.
19. Guan X.L., He X., Ong W.Y., Yeo W.K., Shui G., Wenk M.R. Non-targeted profiling of lipids during kainate-induced neuronal injury. FASEB J 2006, 20:1152-1161.
20. Han X., Holtzman D.M., McKeel D.W., Kelley J., Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 2002, 82:809-818.
21. Joghataie M.T., Roghani M., Jalali M.R., Baluchnejadmojarad T., Sharayeli M. Dendritic spine changes in medial prefrontal cortex of male diabetic rats using Golgi-impregnation method. Arch Iran Med 2007, 10:54-58.
22. Johnson V.J., He Q., Osuchowski M.F., Sharma R.P. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. Toxicology 2004, 201:67-75.
23. Kilkus J.P., Goswami R., Dawson S.A., Testai F.D., Berdyshev E.V., Han X., Dawson G. Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons. J Neurochem 2008, 106:1745-1757.
24. Kim S., Steelman A.J., Zhang Y., Kinney H.C., Li J. Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol 2012, 22:41-57.
25. Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008, 29:494-511.
26. Kroner Z. The relationship between Alzheimer's disease and diabetes: type 3 diabetes?. Altern Med Rev 2009, 14:373-379.
27. Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002, 946:221-231.
28. Li Z.G., Zhang W., Sima A.A. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res 2005, 1037:12-24.
29. Mahadevappa V.G., Holub B.J. Chromatographic analysis of phosphoinositides and their breakdown products in activated blood platelets/neutrophils. Chromatography of lipids in biomedical research and clinical diagnosis 1987, 225-265. Elsevier, Amsterdam. A. Kuksis (Ed.).
30. Malone J.I., Hanna S., Saporta S., Mervis R.F., Park C.R., Chong L., Diamond D.M. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 2008, 9:531-539.
31. Martínez-Tellez R., Gómez-Villalobos Mde J., Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 2005, 1048:108-115.
32. Massey J.B. Interaction of ceramides with phosphatidylcholine, sphingomyelin and sphingomyelin/cholesterol bilayers. Biochim Biophys Acta 2001, 1510:167-184.
33. McCrimmon R.J., Sherwin R.S. Hypoglycemia in type 1 diabetes. Diabetes 2010, 59(10):2333-2339.
34. Mencarelli C., Martinez-Martinez P. Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci 2013, 70:181-203.
35. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science 1993, 259:1769-1771.
36. Ohtani R., Tomimoto H., Kondo T., Wakita H., Akiguchi I., Shibasaki H., Okazaki T. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res 2004, 1023:31-40.
37. Osuchowski M.F., Johnson V.J., He Q., Sharma R.P. Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice. Toxicol Lett 2004, 147:87-94.
38. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999, 53:1937-1942.
39. Pinto S.N., Silva L.C., Futerman A.H., Prieto M. Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation. Biochim Biophys Acta 2011, 1808:2753-2760.
40. Ruangsiriluk W., Grosskurth S.E., Ziemek D., Kuhn M., des Etages S.G., Francone O.L. Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression. J Lipid Res 2012, 53:1459-1471.
41. Satoi H., Tomimoto H., Ohtani R., Kitano T., Kondo T., Watanabe M., Oka N., Akiguchi I., Furuya S., Hirabayashi Y., Okazaki T. Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 2005, 130:657-666.
42. Singh S., Swarnkar S., Goswami P., Nath C. Astrocytes and microglia: responses to neuropathological conditions. Int J Neurosci 2011, 121:589-597.
43. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem J 2003, 369:199-211.
44. Wang G., Silva J., Dasgupta S., Bieberich E. Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia 2008, 6:449-456.
45. Wayhs C.A., Mescka C.P., Vanzin C.S., Ribas G.S., Guerreiro G., Nin M.S., Manfredini V., Barros H.M., Vargas C.R. Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior. Metab Brain Dis 2013, 28:563-570.
46. Yano M., Kishida E., Muneyuki Y., Masuzawa Y. Quantitative analysis of ceramide molecular species by high performance liquid chromatography. J Lipid Res 1998, 39:2091-2098.
47. Zhu Y., Xu J., Kwong W.H., Wai S.M., Lam W.P., Yew D.T. Microscopic analysis of the different regions of three Alzheimer brains aged 93, 94, and 104years old. Int J Neurosci 2007, 117:1403-1413.